BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35366027)

  • 1. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
    Li N; Xu L; Zhang J; Liu Y
    Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.
    Wang C; Lv X; He C; Davis JS; Wang C; Hua G
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.
    Hou H; Yu X; Cong P; Zhou Y; Xu Y; Jiang Y
    Cell Prolif; 2019 Jul; 52(4):e12617. PubMed ID: 31012173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of FHL2 suppressed trophoblast migration, invasion and epithelial-mesenchymal transition in recurrent miscarriage.
    Luan X; Zhai J; Li S; Du Y
    Reprod Biomed Online; 2024 Jan; 48(1):103342. PubMed ID: 37945432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
    Chen Y; Yang S; Zhou H; Su D
    Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
    Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
    J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
    Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
    Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
    Chen W; Zhang Y; Fang Z; Qi W; Xu Y
    Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.